SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-082444
Filing Date
2020-07-09
Accepted
2020-07-09 18:20:22
Documents
3
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 7755
2 EX-24 ex-24.htm EX-24 11511
3 EX-99.1 ex-99d1.htm EX-99.1 9599
  Complete submission text file 0001104659-20-082444.txt   31017
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO. DUBLIN L2 -----
Business Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO. DUBLIN L2 ----- 353 1 901 5701
Malin Corp plc (Reporting) CIK: 0001673063 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39376 | Film No.: 201021331

Mailing Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ----
Business Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ---- 353 1 901 5701
Malin Life Sciences Holdings Ltd (Reporting) CIK: 0001685138 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39376 | Film No.: 201021330